相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
CID-49852229
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
1430213-30-1
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg/50 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥605.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥250.0 |
| 规格: | 5 mg | 产品价格: | ¥550.0 |
| 规格: | 10 mg | 产品价格: | ¥980.0 |
| 规格: | 25 mg | 产品价格: | ¥1980.0 |
| 规格: | 50 mg | 产品价格: | ¥3000.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
ML216
CAS No. : 1430213-30-1
MCE 国际站:ML216
产品活性:ML216 (CID-49852229) 是一种有效,选择性,细胞渗透性的 BLM 解旋酶抑制剂,对 BLMfull-length 和 BLM636-1298 的 IC50 分别为 2.98 μM 和 0.97 μM。ML216 以 Ki 为 1.76 µM 来抑制 BLM 的 ssDNA 依赖性 ATPase 的活性。ML216 具有抗肿瘤活性。
研究领域:Cell Cycle/DNA Damage
作用靶点:DNA/RNA Synthesis
In Vitro: ML216 (12.5-50 μM; 24-72 hours; PSNG5 and PSNG13cells) treatment inhibits the proliferation of PSNF5 cells in a concentration-dependent manner, but not of PSNG13 cells.
?ML216 treatment leads to a statistically significant increase in the frequency of sister chromatid exchanges (SCEs) in PSNF5 cells, but not in PSNG13 cells.
?ML216 increases the sensitivity of PSNF5 cells to aphidicolin but has no sensitizing effect on isogenic PSNG13 cells devoid of BLM.
?ML216 inhibits both the full length WRN (IC50 of 5 μM) and a truncated WRN500-946 (IC50 of 12.6 μM), with the former being 2.5-fold more sensitive to inhibition. BLM is a little more sensitive than WRN to inhibition by ML216 (1.7-fold based on IC50 values). Despite the detectable inhibition of WRN by ML216, this compound appears selective for BLM in human cells. ML216 inhibits proliferation of WRN+ and WRN? cells equally well, and similarly sensitized both cell types to aphidicolin.
In Vivo: Although ML216 inhibits unwinding by the sequence-related BLM and WRN helicases similarly in vitro, the apparent dependence on BLM for ML216 to exert its biological effects in human cells suggests BLM specificity for the drug’s mechanism of action in vivo. A co-crystal structure of BLM in complex with inhibitor would be informative. Cellular cues in vivo may induce a specific conformation of WRN that makes it resistant to ML216.
相关产品:Covalent Screening Library Plus | Bioactive Compound Library Plus | Cell Cycle/DNA Damage Compound Library | Anti-Cancer Compound Library | Anti-Aging Compound Library | Covalent Screening Library | Heterocyclic Compound Library | Highly Selective Inhibitors Library | Cycloheximide | Actinomycin D | Oxaliplatin | Gemcitabine | Carboplatin | Bleomycin sulfate | Mitomycin C | Cytarabine | Methotrexate | ART558 | Streptozotocin | Anisomycin | Fludarabine | Thymidine | Hydroxyurea | Remdesivir | Daunorubicin hydrochloride | Brequinar | Capecitabine | Branaplam | α-Amanitin | CX-5461 | Folic acid | Urolithin A | Epirubicin hydrochloride | Plicamycin | Levofloxacin
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验1.1463 1.3883 34 1.138 1.1513 1.3902 35 1.177 1.1562 1.3920 36 1.216
Add 1ml of either NaN3 0,05%-PBS or BSGC to the remainig eythrocytes and other cells Cetrifuge at 216-220g , 5-7min , 10ѓC Take & save at 4ѓC PRP (platelet-rich plasma ) Add 1ml of either NaN3 0,05%-PBS or BSGC
Add 1ml of either NaN3 0,05%-PBS or BSGC to the remainig eythrocytes and other cells Cetrifuge at 216-220g , 5-7min , 10ѓC Take & save at 4ѓC PRP (platelet-rich plasma ) Add 1ml of either NaN3 0,05%-PBS or BSGC
技术资料暂无技术资料 索取技术资料

















